Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma
Background: Hepatitis B virus (HBV) infection is one of the major causes of chronic liver disease, which progresses from chronic hepatitis B (CHB) to fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Early detection and laboratory-based screening of hepatocellular carcinoma are still major ch...
Main Authors: | Sonu Kumar, Neeti Nadda, Afnan Quadri, Rahul Kumar, Shashi Paul, Pranay Tanwar, Shivanand Gamanagatti, Nihar Ranjan Dash, Anoop Saraya, Shalimar, Baibaswata Nayak |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2023.1235260/full |
Similar Items
-
Presence of mEGFR ctDNA predicts a poor clinical outcome in lung adenocarcinoma
by: Taehee Kim, et al.
Published: (2019-12-01) -
Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy
by: Franciele H. Knebel, et al.
Published: (2020-12-01) -
Quantitative ctDNA Detection in Hepatoblastoma: Implications for Precision Medicine
by: Smadar Kahana-Edwin, et al.
Published: (2023-12-01) -
Development of Highly Sensitive Digital Droplet PCR for Detection of cKIT Mutations in Circulating Free DNA That Mediate Resistance to TKI Treatment for Gastrointestinal Stromal Tumor (GIST)
by: Michael Rassner, et al.
Published: (2023-03-01) -
Microarray Approach Combined with ddPCR: An Useful Pipeline for the Detection and Quantification of Circulating Tumour DNA Mutations
by: Silvia Galbiati, et al.
Published: (2019-07-01)